A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Outcomes of Radiofrequency Ablation of Lung Tumors
- Status
- SUSPENDED
- Phase
- N/A
A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
- Status
- TERMINATED
- Phase
- PHASE3
Iressa v BSC (Best Supportive Care) in First Line NSCLC
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2